دورية أكاديمية

Antimicrobial-Resistant Nontyphoidal Salmonella Infection Following International Travel-United States, 2018-2019.

التفاصيل البيبلوغرافية
العنوان: Antimicrobial-Resistant Nontyphoidal Salmonella Infection Following International Travel-United States, 2018-2019.
المؤلفون: Ford L; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Shah HJ; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Eikmeier D; Minnesota Department of Health, St Paul, Minnesota, USA., Hanna S; Tennessee Department of Health, Nashville, Tennessee, USA., Chen J; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Tagg KA; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.; ASRT, Inc., Smyrna Georgia, USA., Langley G; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Payne DC; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Plumb ID; Division of Foodborne, Waterborne, and Environmental Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
المصدر: The Journal of infectious diseases [J Infect Dis] 2023 Aug 31; Vol. 228 (5), pp. 533-541.
نوع المنشور: Journal Article; Research Support, U.S. Gov't, P.H.S.
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
أسماء مطبوعة: Publication: Jan. 2011- : Oxford : Oxford University Press
Original Publication: 1904-2010 : Chicago, IL : University of Chicago Press
مواضيع طبية MeSH: Salmonella Infections*/drug therapy , Salmonella Infections*/epidemiology , Anti-Infective Agents*, Humans ; United States/epidemiology ; Microbial Sensitivity Tests ; Salmonella/genetics ; Ciprofloxacin/pharmacology ; Ciprofloxacin/therapeutic use ; Anti-Bacterial Agents/pharmacology ; Anti-Bacterial Agents/therapeutic use
مستخلص: Background: Antimicrobial resistance in nontyphoidal Salmonella (NTS) can limit treatment options. We assessed the contribution of international travel to antimicrobial-resistant NTS infections.
Methods: We describe NTS infections that were reported to the Foodborne Diseases Active Surveillance Network during 2018-2019 and screened for genetic resistance determinants, including those conferring decreased susceptibility to first-line agents (ciprofloxacin, ceftriaxone, or azithromycin). We used multivariable logistic regression to assess the association between resistance and international travel during the 7 days before illness began. We estimated the contribution of international travel to resistance using population-attributable fractions, and we examined reported antimicrobial use.
Results: Among 9301 NTS infections, 1159 (12%) occurred after recent international travel. Predicted resistance to first-line antimicrobials was more likely following travel; the adjusted odds ratio varied by travel region and was highest after travel to Asia (adjusted odds ratio, 7.2 [95% confidence interval, 5.5-9.5]). Overall, 19% (95% confidence interval, 17%-22%) of predicted resistance to first-line antimicrobials was attributable to international travel. More travelers than nontravelers receiving ciprofloxacin or other fluoroquinolones had isolates with predicted resistance to fluoroquinolones (29% vs 9%, respectively; P < .01).
Conclusions: International travel is a substantial risk factor for antimicrobial-resistant NTS infections. Understanding risks of resistant infection could help target prevention efforts.
Competing Interests: Potential conflicts of interest. All authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
(Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.)
References: Foodborne Pathog Dis. 2012 Mar;9(3):245-8. (PMID: 22283668)
N Engl J Med. 2020 Apr 2;382(14):1372-1374. (PMID: 32242366)
PLoS One. 2019 Dec 4;14(12):e0225800. (PMID: 31800600)
Foodborne Pathog Dis. 2011 Sep;8(9):1031-7. (PMID: 21563923)
Epidemiol Infect. 2019 Oct 07;147:e285. (PMID: 31587689)
Emerg Infect Dis. 2001 May-Jun;7(3):382-9. (PMID: 11384513)
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5649-54. (PMID: 25792457)
Foodborne Pathog Dis. 2019 Jul;16(7):457-462. (PMID: 31066584)
Epidemiol Infect. 2018 Mar;146(4):423-429. (PMID: 29409557)
PLoS Med. 2015 Dec 03;12(12):e1001921. (PMID: 26633831)
Clin Infect Dis. 2004 Apr 15;38 Suppl 3:S121-6. (PMID: 15095180)
Clin Infect Dis. 2017 Nov 29;65(12):e45-e80. (PMID: 29053792)
Clin Infect Dis. 2004 Jun 1;38(11):1644-5. (PMID: 15156460)
J Travel Med. 2017 Apr 01;24(suppl_1):S6-S12. (PMID: 28520997)
Microbiol Resour Announc. 2020 Mar 26;9(13):. (PMID: 32217683)
Clin Infect Dis. 2001 Jan 15;32(2):263-9. (PMID: 11170916)
Nature. 2019 Sep;573(7773):276-280. (PMID: 31485077)
Emerg Infect Dis. 2021 Jan;27(1):140-149. (PMID: 33350905)
Zoonoses Public Health. 2018 Nov;65(7):838-849. (PMID: 30027554)
MMWR Morb Mortal Wkly Rep. 2020 May 01;69(17):509-514. (PMID: 32352955)
Foodborne Pathog Dis. 2018 Jul;15(7):428-436. (PMID: 29624414)
Antimicrob Agents Chemother. 2016 Aug 22;60(9):5515-20. (PMID: 27381390)
Lancet Planet Health. 2017 Nov;1(8):e316-e327. (PMID: 29387833)
Emerg Infect Dis. 2011 Jan;17(1):7-15. (PMID: 21192848)
mSphere. 2020 May 27;5(3):. (PMID: 32461269)
Lancet Infect Dis. 2017 Jan;17(1):78-85. (PMID: 27751772)
Lancet Infect Dis. 2019 Dec;19(12):1312-1324. (PMID: 31562022)
Microorganisms. 2022 Jan 26;10(2):. (PMID: 35208747)
معلومات مُعتمدة: CC999999 United States ImCDC Intramural CDC HHS; United States CC CDC HHS
فهرسة مساهمة: Keywords: drug resistance; foodborne disease; salmonella; travel
المشرفين على المادة: 5E8K9I0O4U (Ciprofloxacin)
0 (Anti-Infective Agents)
0 (Anti-Bacterial Agents)
تواريخ الأحداث: Date Created: 20230502 Date Completed: 20230901 Latest Revision: 20240206
رمز التحديث: 20240206
مُعرف محوري في PubMed: PMC10839744
DOI: 10.1093/infdis/jiad128
PMID: 37129066
قاعدة البيانات: MEDLINE
الوصف
تدمد:1537-6613
DOI:10.1093/infdis/jiad128